{"content":"<li class=\"n-box-item date-title\" data-end=\"1539403199\" data-start=\"1539316800\" data-txt=\"Monday, December 23, 2019\">Friday, October 12, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3397130\" data-ts=\"1539380416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397130-after-hours-gainers-losers-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (10/12/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+22.6%</font>. <a href='https://seekingalpha.com/symbol/XYL' title='Xylem, Inc.'>XYL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/FTV' title='Fortive Corporation'>FTV</a> <font color='green'>+6.4%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/RDN' title='Radian Group, Inc.'>RDN</a> <font color='green'>+3.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-3%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='red'>-2.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397130\" data-linked=\"After Hours Gainers / Losers (10/12/2018)\" data-tweet=\"$ACRX $ACRX $XYL - After Hours Gainers / Losers (10/12/2018) https://seekingalpha.com/news/3397130-after-hours-gainers-losers-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397130-after-hours-gainers-losers-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397127\" data-ts=\"1539379010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRU\" target=\"_blank\">PRU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397127-wsj-prudential-close-to-shedding-federal-oversight-sharesplus-1_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Prudential close to shedding federal oversight; shares +1.3%</a></h4><ul>   <li>Regulators may vote as soon as next week on <a href=\"https://www.wsj.com/articles/regulators-consider-relieving-prudential-of-federal-oversight-1539377693?mod=hp_lista_pos4\" target=\"_blank\">removing federal oversight</a> from Prudential Financial (NYSE:<a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a>) -- the last remaining nonbank firm with the \"systemically important financial institution\" designation, <i>The Wall Street Journal</i> notes.</li>    <li>That wouldn't be a surprise move, as it's been expected at some point since the beginning of the Trump administration. As recently as 2016, four nonbank firms were SIFI designated (AIG, GE Capital and MetLife have since been removed).</li>    <li><a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a> is <font color='green'>up 1.3%</font> after hours.</li>    <li>The Financial Stability Oversight Council's Tuesday agenda has a closed-door discussion of &ldquo;an update on the annual re-evaluation of the designation of a nonbank financial company\" which must be Prudential.</li>    <li>Nine of the council's 10 voting members are Trump appointees.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397127\" data-linked=\"WSJ: Prudential close to shedding federal oversight; shares +1.3%\" data-tweet=\"$PRU - WSJ: Prudential close to shedding federal oversight; shares +1.3% https://seekingalpha.com/news/3397127-wsj-prudential-close-to-shedding-federal-oversight-sharesplus-1_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3397127-wsj-prudential-close-to-shedding-federal-oversight-sharesplus-1_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397122\" data-ts=\"1539377939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397122-progenics-pharma-inks-75m-stock-sales-agreement-cantor-fitzgerald\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharma inks $75M stock sales agreement with Cantor Fitzgerald</a></h4><ul><li>Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a>) enters into an <a href=\"https://www.sec.gov/Archives/edgar/data/835887/000143774918018249/prog20181004b_8k.htm\" target=\"_blank\">agreement </a>with Cantor Fitzgerald for the at-the-market sale of up to $75M of its common shares. Cantor will earn a 3% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397122\" data-linked=\"Progenics Pharma inks $75M stock sales agreement with Cantor Fitzgerald\" data-tweet=\"$PGNX - Progenics Pharma inks $75M stock sales agreement with Cantor Fitzgerald https://seekingalpha.com/news/3397122-progenics-pharma-inks-75m-stock-sales-agreement-cantor-fitzgerald?source=tweet\" data-url=\"https://seekingalpha.com/news/3397122-progenics-pharma-inks-75m-stock-sales-agreement-cantor-fitzgerald\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397119\" data-ts=\"1539377261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397119-broadcom-to-close-ca-deal-nov-5-after-eu-japan-approvals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom to close CA deal Nov. 5 after EU, Japan approvals</a></h4><ul>   <li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) says in a filing that <a href=\"https://seekingalpha.com/news/3397066-ca-gains-europe-approves-buyout-broadcom\" target=\"_blank\">today's EU approval</a> was the last pending regulatory OK needed for its $19B takeover of CA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a>), and so it expects to close the deal on Nov. 5.</li>    <li>That is the first day of Broadcom's 2019 fiscal year.</li>    <li>The deal had gotten antitrust approval in Japan on Oct. 2, Broadcom notes.</li>    <li>Broadcom closed the day <font color='green'>up 1.8%</font>; <a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> pared gains somewhat to finish <font color='green'>up 0.5%</font>.</li>    <li><a href=\"https://seekingalpha.com/filing/4200060\" target=\"_blank\">SEC filing</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3397119\" data-linked=\"Broadcom to close CA deal Nov. 5 after EU, Japan approvals\" data-tweet=\"$AVGO $AVGO $CA - Broadcom to close CA deal Nov. 5 after EU, Japan approvals https://seekingalpha.com/news/3397119-broadcom-to-close-ca-deal-nov-5-after-eu-japan-approvals?source=tweet\" data-url=\"https://seekingalpha.com/news/3397119-broadcom-to-close-ca-deal-nov-5-after-eu-japan-approvals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397116\" data-ts=\"1539376734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNOA\" target=\"_blank\">SNOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397116-sonoma-pharma-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonoma Pharma readies equity offering</a></h4><ul><li>Sonoma Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1367083/000168316818003037/sonoma_s1.htm\" target=\"_blank\">prospectus </a>for a $6M public offering of units, each consisting of one common share and a warrant. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397116\" data-linked=\"Sonoma Pharma readies equity offering\" data-tweet=\"$SNOA - Sonoma Pharma readies equity offering https://seekingalpha.com/news/3397116-sonoma-pharma-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3397116-sonoma-pharma-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397113\" data-ts=\"1539375914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397113-progenics-pharma-files-for-250m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharma files for $250M mixed shelf offering</a></h4><ul><li>Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/835887/000143774918018244/prog20181004_s3.htm\" target=\"_blank\">prospectus </a>for a $250M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397113\" data-linked=\"Progenics Pharma files for $250M mixed shelf offering\" data-tweet=\"$PGNX - Progenics Pharma files for $250M mixed shelf offering https://seekingalpha.com/news/3397113-progenics-pharma-files-for-250m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3397113-progenics-pharma-files-for-250m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397111\" data-ts=\"1539375480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397111-rubicon-project-settles-fee-dispute-guardian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon Project settles fee dispute with Guardian</a></h4><ul>   <li>The Rubicon Project (NYSE:<a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a>) clawed back some recent declines, <font color='green'>rising 9.2%</font> today, after news that it reached a <a href=\"https://seekingalpha.com/filing/4199038\" target=\"_blank\">settlement with <i>The Guardian</i></a> over alleged hidden fees.</li>    <li><i>The Guardian</i> alleged that Rubicon Project charged fees to buyers of the paper's ad inventory without disclosing those to the publisher, and sued for damages.</li>    <li>The ad-tech firm countersued last year, saying the paper had consented to the fees by contract and that they were disclosed publicly in SEC filings.</li>    <li>The settlement is confidential.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397111\" data-linked=\"Rubicon Project settles fee dispute with Guardian\" data-tweet=\"$RUBI - Rubicon Project settles fee dispute with Guardian https://seekingalpha.com/news/3397111-rubicon-project-settles-fee-dispute-guardian?source=tweet\" data-url=\"https://seekingalpha.com/news/3397111-rubicon-project-settles-fee-dispute-guardian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397100\" data-ts=\"1539374109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CP\" target=\"_blank\">CP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397100-cp-rail-one-of-worlds-best-managed-railroads-stifel-says-in-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CP Rail one of world&#39;s &#39;best managed&#39; railroads, Stifel says in upgrade</a></h4><ul>     <li>Canadian Pacific Railway (<a href='https://seekingalpha.com/symbol/CP' title='Canadian Pacific Railway Limited'>CP</a> <font color='green'>+2%</font>) is higher after Stifel <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/10/12498995/canadian-pacific-one-of-the-best-managed-most-efficient\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $247 price target, saying it \"did not fully appreciate the opportunities and strategic initiatives the company has in its pipeline.\"</li>     <li>Stifel cites CP's potential to expand capacity in key locations near terminals, the benefits of investment in new equipment such as high-capacity grain cars&nbsp;and recent operational improvements to intermodal operations.</li>     <li>CP is \"one of the best-managed and most efficient railroads in the world,\" and has posted strong volumes recently as it gains market share, Stifel says, adding that a key takeaway from the company's recent investor day was CP's high growth potential, even in the near term.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397100\" data-linked=\"CP Rail one of world&#39;s &#39;best managed&#39; railroads, Stifel says in upgrade\" data-tweet=\"$CP - CP Rail one of world&#39;s &#39;best managed&#39; railroads, Stifel says in upgrade https://seekingalpha.com/news/3397100-cp-rail-one-of-worlds-best-managed-railroads-stifel-says-in-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3397100-cp-rail-one-of-worlds-best-managed-railroads-stifel-says-in-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397099\" data-ts=\"1539373467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTMEY\" target=\"_blank\">GTMEY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397099-china-telecom-telenor-prep-bids-to-enter-philippines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Telecom, Telenor prep bids to enter Philippines</a></h4><ul>   <li>Amid a yearlong push by Philippines President Rodrigo Duterte to open up telecom competition, China Telecom (<a href=\"http://seekingalpha.com/symbol/CHA\" target=\"_blank\">CHA</a> <font color='red'>-1.1%</font>) and Telenor (<a href=\"http://seekingalpha.com/symbol/TELNY\" target=\"_blank\">TELNY</a> <font color='red'>-0.1%</font>) have bought bidding documents allowing them to enter the market, the government says.</li>    <li>&ldquo;This shows the confidence of telcos in the selection process,&rdquo; the country's Information and Communications Secretary Eliseo Rio told Bloomberg.</li>    <li>Seven companies have bought the bidding documents to challenge the duopoly of PLDT (<a href=\"http://seekingalpha.com/symbol/PHI\" target=\"_blank\">PHI</a> <font color='green'>+2.9%</font>) and Globe Telecom (<a href='https://seekingalpha.com/symbol/GTMEY' title='Globe Telecom, Inc. ADR'>OTCPK:GTMEY</a>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394490-philippines-duterte-presses-effort-add-third-telecom\" target=\"_blank\">Philippines' Duterte presses effort to add third telecom</a> (Oct. 02 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317543-philippines-china-telecom-challenge-local-duopoly\" target=\"_blank\">Philippines: China Telecom to challenge local duopoly</a> (Dec. 11 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313584-philippines-courts-chinese-entry-domestic-telecom-market\" target=\"_blank\">Philippines courts Chinese entry into domestic telecom market</a> (Nov. 20 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397099\" data-linked=\"China Telecom, Telenor prep bids to enter Philippines\" data-tweet=\"$GTMEY $GTMEY $CHA - China Telecom, Telenor prep bids to enter Philippines https://seekingalpha.com/news/3397099-china-telecom-telenor-prep-bids-to-enter-philippines?source=tweet\" data-url=\"https://seekingalpha.com/news/3397099-china-telecom-telenor-prep-bids-to-enter-philippines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397095\" data-ts=\"1539373152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397095-stocks-regroup-move-sharply-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks regroup, move sharply higher</a></h4><ul><li>It was shaping up to be another ugly session as the averages gave up big early gains and turned negative in early afternoon trade. But there's been another reversal and the Dow (<font color='green'>+1%</font>), S&amp;P 500 (<font color='green'>+1.2%</font>), and Nasdaq (<font color='green'>+2%</font>) have all moved back to near session highs with 20 minutes to go before the closing bell.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397095\" data-linked=\"Stocks regroup, move sharply higher\" data-tweet=\"Stocks regroup, move sharply higher https://seekingalpha.com/news/3397095-stocks-regroup-move-sharply-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3397095-stocks-regroup-move-sharply-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397094\" data-ts=\"1539373048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397094-fda-ad-com-backs-acelrx-pharmas-dsuvia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Com backs AcelRx Pharma&#39;s Dsuvia</a></h4><ul><li>In a 10 - 3 vote, the FDA's Anesthetic and Analgesic Drug Products Advisory Committee recommends approval for AcelRx Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) DSUVIA (sufentanil sublingual tablet) for the management of moderate-to-severe pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.</li><li>Nasdaq has yet to post when shares will resume trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396385-reversal-fortune-acelrx-pharma-shares-26-percent-potential-ad-com-thumbs-dsuvia\" target=\"_blank\">Reversal of fortune for AcelRx Pharma, shares up 26% on potential Ad Com thumbs up for Dsuvia</a> (Oct. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397094\" data-linked=\"FDA Ad Com backs AcelRx Pharma&#39;s Dsuvia\" data-tweet=\"$ACRX - FDA Ad Com backs AcelRx Pharma&#39;s Dsuvia https://seekingalpha.com/news/3397094-fda-ad-com-backs-acelrx-pharmas-dsuvia?source=tweet\" data-url=\"https://seekingalpha.com/news/3397094-fda-ad-com-backs-acelrx-pharmas-dsuvia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397088\" data-ts=\"1539370832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397088-reports-softbank-tapping-goldman-nomura-db-for-massive-telecom-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reports: SoftBank tapping Goldman, Nomura, DB for massive telecom IPO</a></h4><ul>   <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='green'>+2.4%</font>) is readying what may be the <a href=\"https://www.ft.com/content/61bb1bfa-ce28-11e8-b276-b9069bde0956\" target=\"_blank\">biggest initial public offering in history</a> for its Japanese mobile business, with reports on the sale ranging from an offering of &yen;2.3T to &yen;3T (some $20B-$27B worth).</li>    <li>Reports have the conglomerate choosing Goldman Sachs (<a href=\"http://seekingalpha.com/symbol/GS\" target=\"_blank\">GS</a> <font color='red'>-0.3%</font>), Nomura (<a href=\"http://seekingalpha.com/symbol/NMR\" target=\"_blank\">NMR</a> <font color='red'>-1.3%</font>) and Deutsche Bank (<a href=\"http://seekingalpha.com/symbol/DB\" target=\"_blank\">DB</a> <font color='red'>-0.7%</font>) as lead underwriters, with Mizuho and SMBC Nikko Securities also underwriting.</li>    <li>The company reportedly expects to complete the offering by late December.</li>    <li>Alibaba sold $25B worth of shares in New York in 2014, still the biggest-ever IPO.</li>    <li>SoftBank is looking to the Tokyo Stock Exchange to list and most of the issue will be pitched at domestic investors.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397088\" data-linked=\"Reports: SoftBank tapping Goldman, Nomura, DB for massive telecom IPO\" data-tweet=\"$SFTBY $SFTBY $GS - Reports: SoftBank tapping Goldman, Nomura, DB for massive telecom IPO https://seekingalpha.com/news/3397088-reports-softbank-tapping-goldman-nomura-db-for-massive-telecom-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3397088-reports-softbank-tapping-goldman-nomura-db-for-massive-telecom-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397086\" data-ts=\"1539370831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397086-technology-top-5-gainers-losers-of-3_00-pm-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3.00 PM (10/12/2018)</a></h4><ul><li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BSTI' title='Best, Inc.'>BSTI</a> <font color='green'>+8%</font>.</li><li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TNAV' title='Telenav, Inc.'>TNAV</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397086\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3.00 PM (10/12/2018)\" data-tweet=\"$SMAR $SMAR $BITA - Technology - Top 5 Gainers / Losers as of 3.00 PM (10/12/2018) https://seekingalpha.com/news/3397086-technology-top-5-gainers-losers-of-3_00-pm-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397086-technology-top-5-gainers-losers-of-3_00-pm-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397083\" data-ts=\"1539369312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTG\" target=\"_blank\">BTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397083-b2gold-eyes-african-assets-merged-barrick-randgold-may-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B2Gold eyes African assets merged Barrick-Randgold may sell</a></h4><ul>     <li>B2Gold (<a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='green'>+1.6%</font>) CEO Clive Johnson says the miner is <a href=\"https://www.reuters.com/article/b2gold-ma/b2gold-keen-on-any-african-assets-new-barrick-may-sell-ceo-idUSL2N1WS0SL\" target=\"_blank\">interested in any West African assets</a> that Barrick Gold (ABX <font color='red'>-0.5%</font>) may put up for sale after its acquisition of Randgold Resources.</li>     <li>&ldquo;If there are opportunities in West Africa that don&rsquo;t perhaps fit the new Barrick model, in terms of the size of project, or other things, then we&rsquo;d be keen to look,&rdquo; Johnson tells Reuters.</li>     <li>BTG would be particularly interested in projects it can develop to produce 200K oz./year of gold for at least 10 years, as opposed to already-built mines, and investments with a ~20% rate of return at gold prices of $1,200-$1,250/oz., Johnson says.</li>     <li>BTG shares have climbed as much as 3% today following better than expected <a href=\"https://seekingalpha.com/news/3396982-b2gold-reports-record-q3-production-revenue-double\" target=\"_blank\">Q3 production results</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397083\" data-linked=\"B2Gold eyes African assets merged Barrick-Randgold may sell\" data-tweet=\"$BTG $BTG $GOLD - B2Gold eyes African assets merged Barrick-Randgold may sell https://seekingalpha.com/news/3397083-b2gold-eyes-african-assets-merged-barrick-randgold-may-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3397083-b2gold-eyes-african-assets-merged-barrick-randgold-may-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397081\" data-ts=\"1539368735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRGDF\" target=\"_blank\">DRGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397081-detour-gold-says-paulson-rejects-settlement-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Detour Gold says Paulson rejects settlement proposal</a></h4><ul>     <li>Detour Gold (<a href='https://seekingalpha.com/symbol/DRGDF' title='Detour Gold Corp.'>OTCPK:DRGDF</a> <font color='red'>-2.3%</font>) says John Paulson's hedge fund has <a href=\"https://www.reuters.com/article/detour-gold-paulson/update-2-paulson-rejects-settlement-with-detour-gold-idUSL4N1WS50X\" target=\"_blank\">rejected its proposal</a> to settle a proxy dispute over the company&rsquo;s future.</li>     <li>Detour says the settlement it proposed to Paulson on Oct. 9 would have resulted in nearly half of its board being refreshed in six weeks, with interim CEO Michael Kenyon stepping down before the next annual general meeting.</li>     <li>Paulson says it has made alternative proposals to Detour and will continue to press for a complete change of the board.</li>     <li>The hedge fund has called for Detour to explore strategic alternatives including a sale, and in July called for a special shareholders meeting and nominated eight new directors for appointment to Detour&rsquo;s board.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397081\" data-linked=\"Detour Gold says Paulson rejects settlement proposal\" data-tweet=\"$DRGDF - Detour Gold says Paulson rejects settlement proposal https://seekingalpha.com/news/3397081-detour-gold-says-paulson-rejects-settlement-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/3397081-detour-gold-says-paulson-rejects-settlement-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397077\" data-ts=\"1539367564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGC\" target=\"_blank\">IGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397077-energy-materials-top-5-gainers-losers-of-2-05-pm-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials  - Top 5 Gainers / Losers as of 2:05 PM (10/12/2018)</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc'>SSRM</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SDR' title='SandRidge Mississippian Trust II'>SDR</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397077\" data-linked=\"Energy/Materials  - Top 5 Gainers / Losers as of 2:05 PM (10/12/2018)\" data-tweet=\"$IGC $IGC $SSRM - Energy/Materials - Top 5 Gainers / Losers as of 2:05 PM (10/12/2018) https://seekingalpha.com/news/3397077-energy-materials-top-5-gainers-losers-of-2-05-pm-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397077-energy-materials-top-5-gainers-losers-of-2-05-pm-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397076\" data-ts=\"1539367446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSCI\" target=\"_blank\">MSCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397076-msci-completes-investorforce-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSCI completes InvestorForce sale</a></h4><ul><li>        MSCI (NYSE:<a href='https://seekingalpha.com/symbol/MSCI' title='MSCI, Inc.'>MSCI</a>) completes its sale of InvestorForce to Resurgens Technology Partners for undisclosed terms.</li><li>               The deal was first announced at the end of July.&nbsp;</li><li>               MSCI shares are&nbsp;<font color='green'>up 1%</font>&nbsp;to $153.12.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397076\" data-linked=\"MSCI completes InvestorForce sale\" data-tweet=\"$MSCI - MSCI completes InvestorForce sale https://seekingalpha.com/news/3397076-msci-completes-investorforce-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3397076-msci-completes-investorforce-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397067\" data-ts=\"1539364058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397067-mylan-prevails-in-patent-challenge-to-tevas-copaxone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan prevails in patent challenge to Teva&#39;s Copaxone</a></h4><ul><li>The U.S. Court of Appeals for the Federal Circuit has <a href=\"https://seekingalpha.com/pr/17299295-mylan-prevails-copaxone-40mg-ml-litigation-teva-u-s-appellate-court\" target=\"_blank\">affirmed </a>a district court ruling invalidating Teva Pharmaceutical Industries' (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+3.9%</font>) 40 mg/mL dosing patents for MS med Copaxone (glatiramer acetate) as obvious.</li><li>These particular patents, four of them, were the last remaining infringement cases involving Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-2.4%</font>) and its generic 40 mg/mL version.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397067\" data-linked=\"Mylan prevails in patent challenge to Teva&#39;s Copaxone\" data-tweet=\"$TEVA $TEVA $MYL - Mylan prevails in patent challenge to Teva&#39;s Copaxone https://seekingalpha.com/news/3397067-mylan-prevails-in-patent-challenge-to-tevas-copaxone?source=tweet\" data-url=\"https://seekingalpha.com/news/3397067-mylan-prevails-in-patent-challenge-to-tevas-copaxone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397065\" data-ts=\"1539363958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDC\" target=\"_blank\">CLDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397065-financials-top-5-gainers-losers-of-1-05-pm-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:05 PM (10/12/2018)</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco FrancÃ©s S.A.  ADR'>BFR</a> <font color='green'>+8%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/GLRE' title='Greenlight Capital Re, Ltd.'>GLRE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KMPR' title='Kemper Corporation'>KMPR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397065\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:05 PM (10/12/2018)\" data-tweet=\"$CLDC $CLDC $LEJU - Financials - Top 5 Gainers / Losers as of 1:05 PM (10/12/2018) https://seekingalpha.com/news/3397065-financials-top-5-gainers-losers-of-1-05-pm-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397065-financials-top-5-gainers-losers-of-1-05-pm-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397062\" data-ts=\"1539363276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397062-stocks-continue-to-fade-dow-turns-negative\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks continue to fade - Dow turns negative</a></h4><ul><li>This morning's big rally in the Dow and S&amp;P 500 has been completely snuffed out in early afternoon action, with the Nasdaq - earlier up more than 2% - is clinging to a<font color='green'> 0.65% gain</font>.</li><li>Financials are leading the fade as investors sell the mostly good earnings news. Also in the red is the industrial sector, led by a&nbsp;<font color='red'>2.25% decline</font>&nbsp;in GE after that company - under new management - delayed its Q3 report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397062\" data-linked=\"Stocks continue to fade - Dow turns negative\" data-tweet=\"Stocks continue to fade - Dow turns negative https://seekingalpha.com/news/3397062-stocks-continue-to-fade-dow-turns-negative?source=tweet\" data-url=\"https://seekingalpha.com/news/3397062-stocks-continue-to-fade-dow-turns-negative\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397058\" data-ts=\"1539362828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORI\" target=\"_blank\">CORI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397058-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CORI' title='Corium International, Inc.'>CORI</a> <font color='green'>+51%</font>. <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ZOM' title='Zomedica Pharmaceuticals Corp.'>OTC:ZOM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/REPL' title='Replimune Group'>REPL</a> <font color='green'>+14%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a>&nbsp;<font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a>&nbsp;<font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a>&nbsp;<font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RMBL' title='RumbleON, Inc.'>RMBL</a>&nbsp;<font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a>&nbsp;<font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>&nbsp;<font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a>&nbsp;<font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BIOL' title='Biolase, Inc.'>BIOL</a>&nbsp;<font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>&nbsp;<font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ORPN' title='Bio Blast Pharma'>ORPN</a>&nbsp;<font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397058\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CORI $CORI $YGYI - Midday Gainers / Losers https://seekingalpha.com/news/3397058-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3397058-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397051\" data-ts=\"1539360606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397051-take-shot-of-tesla-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Take a shot of Tesla news</a></h4><ul> <li>Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+0.7%</font>) has filed an application with the U.S. Patent and Trademark Office to trademark \"Teslaquila\" for the potential use of a distilled agave liquor and distilled blue agave liquor.</li> <li>CNBC reports that while there is no guarantee that a tequila product from Tesla will make it to the market, the company filed an \"intent to use\" trademark for Teslaquila - meaning it has a good faith intention to apply the patent in the future. Any way you take the development it doesn't appear necessary to go wake up Jose Cuervo.</li> <li>Surprisingly, the tequila action is the first federal trademark application of the calendar year for Tesla.</li> <li>Also today, The Verge has an interesting <a href=\"https://www.theverge.com/2018/10/12/17965382/tesla-chairman-james-murdoch-board-director-rumors-elon-musk\" target=\"_blank\">view</a>&nbsp;on the Tesla chairman speculation. Elizabeth Lopatto connects the dots to surmise that Elon Musk wants Antonio Gracias as the chairman instead of the less-friendly James Murdoch. \"About the only person on the board who&rsquo;s enough of a ruthless bastard to rein Elon Musk in &mdash; or fire him, if it comes to that &mdash; is James Murdoch. Musk knows that, too. If Musk truly wants to outwit Murdoch, he&rsquo;d better abandon the Gracias plan and pick a new independent board member to serve as chair instead. Because if Murdoch does take the board, part of his duties include succession planning for senior executives. That&rsquo;s probably not good news for Musk,\" she writes.</li> <li>Over at Electrek, the latest report is that Tesla is increasing the <a href=\"https://electrek.co/2018/10/12/tesla-powerwall-price-increase/\" target=\"_blank\">price</a> of the Powerwall amid strong demand.</li> <li>Meanwhile, Bond Angle posted a new update on Tesla as it maintained an Underperform rating on the 5.3% senior note issue due in 2025. Analyst Vicki Bryan is wary on Tesla's Q3 results amid what she calls the \"general chaos and inefficiency\" at the company. Bryan expects Tesla to burn through more cash than anticipated.</li> <li>Finally, earlier this week, a new Tesla vehicle counter jumped to the <a href=\"https://www.forbes.com/sites/jeanbaptiste/2018/10/09/tesla-outsells-mercedes-benz-in-america-and-bmw-is-next/#54ea11357562\" target=\"_blank\">forefront</a> when Atherton Research said Tesla outsold Mercedes-Benz in the U.S. during Q3 (69,925 3/S/X units vs 66,542 Mercedes units). Atherton also said that it expects Tesla to also outsell Mercedes during Q4 as production accelerates.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397051\" data-linked=\"Take a shot of Tesla news\" data-tweet=\"$TSLA - Take a shot of Tesla news https://seekingalpha.com/news/3397051-take-shot-of-tesla-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3397051-take-shot-of-tesla-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>171&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397048\" data-ts=\"1539360114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397048-consumer-top-5-gainers-losers-of-12-00-pm-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397048\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/12/2018)\" data-tweet=\"$YGYI $YGYI $FNKO - Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/12/2018) https://seekingalpha.com/news/3397048-consumer-top-5-gainers-losers-of-12-00-pm-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397048-consumer-top-5-gainers-losers-of-12-00-pm-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397046\" data-ts=\"1539359598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397046-cleveland-cliffs-new-labor-contract-ratified-steelworkers-union\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs new labor contract ratified by steelworkers union</a></h4><ul>     <li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+2.5%</font>) says its employees at four mines in Michigan and Minnesota who are represented by the United Steelworkers union have <a href=\"https://www.crainscleveland.com/manufacturing/steelworkers-ratify-four-year-labor-contract-cleveland-cliffs\" target=\"_blank\">ratified a new, four-year labor contract</a>.</li>     <li>CLF says the contract is retroactively effective from Oct. 1 and runs through Sept. 30, 2022; the deal covers ~1,800 USW-represented workers at CLF's Tilden and  Empire mines in Michigan, and its United Taconite and Hibbing Taconite  mines in Minnesota.</li>     <li>Contract details are not disclosed, but the new labor deal reportedly provides steelworkers with a signing bonus, wage  increases in each year of the contract and pension improvements.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397046\" data-linked=\"Cleveland-Cliffs new labor contract ratified by steelworkers union\" data-tweet=\"$CLF - Cleveland-Cliffs new labor contract ratified by steelworkers union https://seekingalpha.com/news/3397046-cleveland-cliffs-new-labor-contract-ratified-steelworkers-union?source=tweet\" data-url=\"https://seekingalpha.com/news/3397046-cleveland-cliffs-new-labor-contract-ratified-steelworkers-union\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397045\" data-ts=\"1539359497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBE\" target=\"_blank\">KBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397045-stocks-giving-up-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks giving up some gains</a></h4><ul><li>Up more than 1% earlier in the session, the S&amp;P 500 is now<font color='green'> ahead 0.9%</font>&nbsp;and Dow<font color='green'> just 0.6%</font>.</li><li>The banks were nicely higher early today after JPMorgan, Citigroup, Wells Fargo, and PNC reported pleasing Q3s. The big players have given up much of their gains though, <a href=\"https://seekingalpha.com/news/3397041-regional-bank-stock-dip-pncs-q3-loans-deposits-disappoint\" target=\"_blank\">and the regionals are</a> sharply lower, <a href=\"https://seekingalpha.com/news/3397041-regional-bank-stock-dip-pncs-q3-loans-deposits-disappoint\" target=\"_blank\">with some pointing</a> to disappointing loan growth out of PNC. The SPDR S&amp;P Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='red'>-1.6%</font>).</li><li>The Nasdaq remains very strong,<font color='green'> up 1.5%</font>, though it was ahead well over 2% about 90 minutes ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397045\" data-linked=\"Stocks giving up some gains\" data-tweet=\"$KBE - Stocks giving up some gains https://seekingalpha.com/news/3397045-stocks-giving-up-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3397045-stocks-giving-up-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397044\" data-ts=\"1539358994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTES\" target=\"_blank\">NTES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397044-reports-baidu-takes-strategic-position-in-netease-music\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reports: Baidu takes strategic position in NetEase Music</a></h4><ul>   <li>NetEase (NASDAQ:<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc'>NTES</a>) is <font color='green'>up 5%</font> in U.S. trading after word of a new funding round for its Cloud Music unit that has a strategic position from Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='green'>+2.9%</font>).</li>    <li>Boyu Capital and General Atlantic are also said to take part.</li>    <li>Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color='green'>+7.1%</font>) rival NetEase will remain the controlling shareholder in NetEase Cloud Music after the divestment, while Baidu will act as a strategic partner.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396839-markets-reeling-tencent-music-pauses-ipo\" target=\"_blank\">With markets reeling, Tencent Music pauses IPO</a> (Oct. 11 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397044\" data-linked=\"Reports: Baidu takes strategic position in NetEase Music\" data-tweet=\"$NTES $NTES $BIDU - Reports: Baidu takes strategic position in NetEase Music https://seekingalpha.com/news/3397044-reports-baidu-takes-strategic-position-in-netease-music?source=tweet\" data-url=\"https://seekingalpha.com/news/3397044-reports-baidu-takes-strategic-position-in-netease-music\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397041\" data-ts=\"1539358383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397041-regional-bank-stock-dip-pncs-q3-loans-deposits-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regional bank stock dip as PNC&#39;s Q3 loans, deposits disappoint</a></h4><ul><li>SPDR S&amp;P Regional Banking ETF (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> <font color='red'>-1.5%</font>) dips as one of its components PNC Financial Services (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='red'>-4.9%</font>) reports Q3 results reflecting softer growth in loans and deposits than analysts expected.</li><li>PNC, the first of large regional banks to report, slumped as much as 5.8% even as Q3 EPS of $2.82 beat consensus estimate of $2.73. But a few other measures fell short of expectations.</li><li>Ending loans of $223.1B, flat from Q2 end, missed FactSet estimate of $225.6B and ending deposits at $264.9B compare with $266.9B estimate.</li><li>Book value per-share at $93.22 vs FS estimate of $94.91.</li><li>Other KRE components falling: KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='red'>-1.7%</font>), SunTrust Banks (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='red'>-1.3%</font>),&nbsp; Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='red'>-1.7%</font>), CIT Group (<a href='https://seekingalpha.com/symbol/CIT' title='CIT Group Inc.'>CIT</a> <font color='red'>-1.1%</font>), and BB&amp;T (<a href='https://seekingalpha.com/symbol/BBT' title='BB&T Corporation'>BBT</a> <font color='red'>-1%</font>).</li><li>By contrast, the big banks gain after JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-0.4%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+1.7%</font>), and Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='green'>+1.2%</font>) report Q3 earnings. Financial Select Sector SPDR ETF (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+0.2%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396931-pnc-sinks-premarket-even-q3-beat\" target=\"_blank\">PNC sinks premarket even with Q3 beat</a> (Oct. 12)</li><li>Regional bank ETFs: <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>, <a href='https://seekingalpha.com/symbol/IAT' title='iShares U.S. Regional Banks ETF'>IAT</a>, <a href='https://seekingalpha.com/symbol/KBWB' title='Invesco KBW Bank Portfolio ETF'>KBWB</a>, <a href='https://seekingalpha.com/symbol/QABA' title='First Trust Nasdaq ABA Community Bank ETF'>QABA</a>, <a href='https://seekingalpha.com/symbol/KBWR' title='Invesco KBW Regional Banking Portfolio ETF'>KBWR</a>, <a href='https://seekingalpha.com/symbol/DPST' title='Direxion Daily Regional Banks Bull 3x Shares ETF'>DPST</a>, <a href='https://seekingalpha.com/symbol/WDRW' title='Direxion Daily Regional Banks Bear 3x Shares ETF'>WDRW</a>, <a href='https://seekingalpha.com/symbol/FTXO' title='First Trust Nasdaq Bank ETF'>FTXO</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397041\" data-linked=\"Regional bank stock dip as PNC&#39;s Q3 loans, deposits disappoint\" data-tweet=\"$PNC $KRE $PNC - Regional bank stock dip as PNC&#39;s Q3 loans, deposits disappoint https://seekingalpha.com/news/3397041-regional-bank-stock-dip-pncs-q3-loans-deposits-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3397041-regional-bank-stock-dip-pncs-q3-loans-deposits-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397040\" data-ts=\"1539358092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMY-OLD\" target=\"_blank\">IMMY-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397040-imprimis-pharma-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imprimis Pharma up 15%</a></h4><ul><li>Thinly traded <a href=\"https://www.imprimisrx.com/why-imprimisrx/our-approach/\" target=\"_blank\">Imprimis Pharmaceuticals</a> (<a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+15.2%</font>) is the latest tiny biotech/drugmaker to spike. Shares are up on more than 50% higher volume, albeit on turnover of only 245K.</li><li>The company uses compounding pharmacies to formulate and distribute its offerings, focused on ophthalmic uses.</li><li>At the end June it had $4.2M in cash and equivalents. Operations generated $400K in cash in H1.</li><li>Q2 sales were $10.4M, up 53% from a year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397040\" data-linked=\"Imprimis Pharma up 15%\" data-tweet=\"$IMMY-OLD - Imprimis Pharma up 15% https://seekingalpha.com/news/3397040-imprimis-pharma-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3397040-imprimis-pharma-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397035\" data-ts=\"1539356720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRI\" target=\"_blank\">DRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397035-oppenheimer-confident-on-darden-restaurants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer confident on Darden Restaurants</a></h4><ul> <li>Oppenheimer checks in on Outperform-rated Darden Restaurants (<a href='https://seekingalpha.com/symbol/DRI' title='Darden Restaurants, Inc.'>DRI</a> <font color='green'>+2.2%</font>) after meeting with the company's management team.</li> <li>\"Several drivers bolster our confidence in Street&rsquo;s current SSS outlook and we believe EPS estimates carry a favorable risk/reward&mdash;a difficult dynamic to find in the space,\" advises the firm.</li> <li>Interestingly, Oppenheimer thinks Darden will be aggressive with restaurant M&amp;A.</li> <li>The Oppenheimer analyst team has a price target of $130 on Darden. The 52-week high on Darden is $124.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397035\" data-linked=\"Oppenheimer confident on Darden Restaurants\" data-tweet=\"$DRI - Oppenheimer confident on Darden Restaurants https://seekingalpha.com/news/3397035-oppenheimer-confident-on-darden-restaurants?source=tweet\" data-url=\"https://seekingalpha.com/news/3397035-oppenheimer-confident-on-darden-restaurants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397033\" data-ts=\"1539356628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORI\" target=\"_blank\">CORI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397033-healthcare-top-5-gainers-losers-of-11-00-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CORI' title='Corium International, Inc.'>CORI</a> <font color='green'>+51%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ATXI' title='Avenue Therapeutics'>ATXI</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BIOL' title='Biolase, Inc.'>BIOL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397033\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/12/2018)\" data-tweet=\"$CORI $CORI $RIOT - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/12/2018) https://seekingalpha.com/news/3397033-healthcare-top-5-gainers-losers-of-11-00-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397033-healthcare-top-5-gainers-losers-of-11-00-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397031\" data-ts=\"1539356330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USX\" target=\"_blank\">USX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397031-checking-in-on-trucking-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Checking in on trucking stocks</a></h4><ul> <li>The trucking sector keeps running into roadblocks as labor shortages, trade war complications, higher oil prices and hurricane logistics issues all arrive just as contract pricing is reported to be falling back a bit.</li> <li>Last week, Wolfe Research <a href=\"https://seekingalpha.com/news/3395477-wolfe-research-warns-five-trucking-stocks\" target=\"_blank\">warned</a> on slower freight volume and pricing growth over the next two years for the trucking industry.</li> <li>The leading decliners in the sector over the last 30 days are U.S. Express (NYSE:<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises'>USX</a>) -30%, USA Truck (NASDAQ:<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a>) -24%, Echo Global Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/ECHO' title='Echo Global Logistics, Inc.'>ECHO</a>) -24%, ArcBest (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a>) -21% and Saia (NASDAQ:<a href='https://seekingalpha.com/symbol/SAIA' title='Saia, Inc.'>SAIA</a>) -21%. The only two trucking stocks to ride higher over the same period are P.A.M. Transportation Services (NASDAQ:<a href='https://seekingalpha.com/symbol/PTSI' title='P.A.M. Transportation Services, Inc.'>PTSI</a>) +8% and Patriot Transportation (NASDAQ:<a href='https://seekingalpha.com/symbol/PATI' title='Patriot Transportation Holding, Inc.'>PATI</a>) +5%. On a YTD look, the biggest decliners are Daseke (NASDAQ:<a href='https://seekingalpha.com/symbol/DSKE' title='Daseke, Inc.'>DSKE</a>) -49% and YRC Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a>) -40%.</li> <li>The recent downturn in trucking names has led to some valuations falling below historic norms. Covenant Transportation (NASDAQ:<a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a>), USA Truck, U.S. Xpress Enterprises (<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises'>USX</a>) and YRC Worldwide all trade with a single-digit forward PE ratio.</li><li><strong>Your turn:</strong> Which trucking stock looks the most attractive to hold right now?</li></ul><div class=\"tiny-share-widget\" data-id=\"3397031\" data-linked=\"Checking in on trucking stocks\" data-tweet=\"$USX $USX $USAK - Checking in on trucking stocks https://seekingalpha.com/news/3397031-checking-in-on-trucking-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3397031-checking-in-on-trucking-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397030\" data-ts=\"1539356321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397030-advisers-to-brazil-presidential-front-runner-clash-over-petrobras\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advisers to Brazil presidential front-runner clash over Petrobras</a></h4><ul>     <li>Nationalistic and free market advisers to Brazil presidential front-runner Jair Bolsonaro are <a href=\"https://www.reuters.com/article/us-brazil-election-petrobras-analysis/brazil-presidential-frontrunners-advisers-clash-over-petrobras-idUSKCN1MM1GS\" target=\"_blank\">deeply divided</a> about the future of the Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+3.2%</font>) state-run oil company, foreshadowing a showdown over divestments and fuel subsidies, Reuters reports.</li>     <li>Adviser Paulo Guedes, a banker educated at the University of Chicago, has said he favors full privatization of PBR, and others believe Bolsonaro would promote a business-friendly agenda such as asset sales to reduce the company&rsquo;s $74B net debt.</li>     <li>But an increasingly vocal cadre of military generals stressing the importance of maintaining PBR as a strategic asset have shown growing influence, according to the report.</li>     <li>Bolsonaro himself supported this year's truckers strike over rising diesel prices and voted as a legislator to preserve the company&rsquo;s monopoly on exploration and production, but as a candidate he has taken a wide range of stances.</li>     <li>In a recent interview, Bolsonaro said he opposed privatizing PBR but still could reluctantly move to end the company&rsquo;s &ldquo;monopoly&rdquo; in Brazil that he said gave it excessive pricing power.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397030\" data-linked=\"Advisers to Brazil presidential front-runner clash over Petrobras\" data-tweet=\"$PBR - Advisers to Brazil presidential front-runner clash over Petrobras https://seekingalpha.com/news/3397030-advisers-to-brazil-presidential-front-runner-clash-over-petrobras?source=tweet\" data-url=\"https://seekingalpha.com/news/3397030-advisers-to-brazil-presidential-front-runner-clash-over-petrobras\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397029\" data-ts=\"1539355697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORI\" target=\"_blank\">CORI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397029-corium-up-51-on-go-private-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corium up 51% on go-private deal</a></h4><ul><li>Thinly traded Corium International (<a href='https://seekingalpha.com/symbol/CORI' title='Corium International, Inc.'>CORI</a> <font color='green'>+50.7%</font>) is up on a whopping 83x surge in volume following its <a href=\"https://seekingalpha.com/pr/17298569-corium-announces-agreement-gurnet-point-capital-purchase-outstanding-shares\" target=\"_blank\">announcement </a>that Gurnet Point Capital will acquire its outstanding shares at $12.50 each.</li><li>The transaction also includes a Contingent Value Right &#40;CVR&#41; of $0.50 per share payable upon FDA approval for lead candidate Corplex Donepezil for Alzheimer's disease prior to March 31, 2020.</li><li>The deal should close by year-end. Afterward, Corium will offer to repurchase all of its $120M in convertible debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397029\" data-linked=\"Corium up 51% on go-private deal\" data-tweet=\"$CORI - Corium up 51% on go-private deal https://seekingalpha.com/news/3397029-corium-up-51-on-go-private-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3397029-corium-up-51-on-go-private-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397028\" data-ts=\"1539355210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397028-comcastplus-1_7-jpmorgan-sees-upside-in-core-cable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast +1.7% as JPMorgan sees upside in core cable</a></h4><ul>   <li>There's upside to Q3 estimates at Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>), JPMorgan says, with the company's core cable business doing well this year along with NBC TV.</li>    <li>Shares are <font color='green'>up 1.7%</font> on strong volume.</li>    <li>Analyst Philip Cusick rates the stock Overweight, noting \"solid cable segment growth, combined with an improved NBCU, makes for a strong and well-diversified cash flow stream.\" A mix shift to higher revenues in broadband and business services should persist, reaching about 50% of cable revenues by 2020, he says. (h/t Bloomberg)</li>    <li>There's risk, though, in the company's pricey push for Sky (<a href='https://seekingalpha.com/symbol/SKYAY' title='Sky Plc ADR'>OTCPK:SKYAY</a>): \"To be clear, we don't love the Sky deal,\" he says, noting it takes a simple U.S.-focused story and adds debt and complexity, and invites competition from the likes of Amazon and Google vs. Comcast's \"clear ambition to be a European or even a pan-Western OTT provider.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397028\" data-linked=\"Comcast +1.7% as JPMorgan sees upside in core cable\" data-tweet=\"$CMCSA $CMCSA $SKYAY - Comcast +1.7% as JPMorgan sees upside in core cable https://seekingalpha.com/news/3397028-comcastplus-1_7-jpmorgan-sees-upside-in-core-cable?source=tweet\" data-url=\"https://seekingalpha.com/news/3397028-comcastplus-1_7-jpmorgan-sees-upside-in-core-cable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397026\" data-ts=\"1539355067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397026-visa-nike-leading-dow-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Visa,Nike leading Dow gainers</a></h4><ul> <li>Two consumer giants are the leading gainers in the Dow today, with Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) <font color='green'>up 4.22%</font> and Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) showing a <font color='green'>2.78% rise</font>.</li> <li>It's pretty easy to draw a line from the strong volume details in the earnings reports of major banks today to the rally in Visa, while Nike is up on some anecdotal reports that its exclusive China-only shoes are performing well.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397026\" data-linked=\"Visa,Nike leading Dow gainers\" data-tweet=\"$V $V $NKE - Visa,Nike leading Dow gainers https://seekingalpha.com/news/3397026-visa-nike-leading-dow-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3397026-visa-nike-leading-dow-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397023\" data-ts=\"1539354634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397023-youngevity-internationalplus-30-on-good-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Youngevity International +30% on good buzz</a></h4><ul> <li>Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) breaks&nbsp;<font color='green'>30% higher</font> in early trading and carved out a new multi-year high of $13.47.</li> <li>A <a href=\"https://seekingalpha.com/pr/17299057-cannabisnewswire-announces-cbd-key-myriad-health-products-across-globe\" target=\"_blank\">press release</a> was issued earlier today on CannabisNewsWire highlighting how \"CBD is exploding into the mainstream wellness\" and mentioning Youngevity.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397023\" data-linked=\"Youngevity International +30% on good buzz\" data-tweet=\"$YGYI - Youngevity International +30% on good buzz https://seekingalpha.com/news/3397023-youngevity-internationalplus-30-on-good-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3397023-youngevity-internationalplus-30-on-good-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397021\" data-ts=\"1539354246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNE\" target=\"_blank\">VNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397021-veoneerminus-3-after-evercore-turns-skittish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veoneer -3% after Evercore turns skittish</a></h4><ul> <li>Shares of Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) is <font color='red'>down 2.80%</font> after Evercore ISI slaps a downgrade on the Swedish auto supplier to Underperform from Market Perform.</li> <li>The firm is nervous about how Veoneer's 2019 guidance will look.</li> <li>Evercore keeps a price target of $35 on VNE. Shares of Veoneer have traded in a range of $39.50 to $57.93 over the last 52 weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397021\" data-linked=\"Veoneer -3% after Evercore turns skittish\" data-tweet=\"$VNE - Veoneer -3% after Evercore turns skittish https://seekingalpha.com/news/3397021-veoneerminus-3-after-evercore-turns-skittish?source=tweet\" data-url=\"https://seekingalpha.com/news/3397021-veoneerminus-3-after-evercore-turns-skittish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397014\" data-ts=\"1539352863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397014-spotifyplus-5_9-amid-pivotals-boost-back-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify +5.9% amid Pivotal&#39;s boost back to Buy</a></h4><ul>   <li>Spotify (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify'>SPOT</a>) is <font color='green'>up 5.9%</font> today after an upgrade from Pivotal Research, part of a set of updates that includes new <a href=\"https://seekingalpha.com/news/3396960-pivotal-upgrades-snap-says-go-private-snap-plus-4-percent\" target=\"_blank\">bullish commentary on Snap</a> and <a href=\"https://seekingalpha.com/news/3396968-twitter-plus-2_6-percent-pivotal-upgrade\" target=\"_blank\">Twitter</a> among others.</li>    <li>The firm boosted its Spotify rating to Buy from Hold.</li>    <li>Pivotal had issued <a href=\"https://seekingalpha.com/news/3373440-spotify-minus-1_5-percent-pivotal-issues-first-downgrade\" target=\"_blank\">Spotify's first downgrade</a> (going to Hold from Buy) in July, a day before earnings.</li>    <li>Shares have pulled back heavily in the past month, <font color='red'>down 17.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397014\" data-linked=\"Spotify +5.9% amid Pivotal&#39;s boost back to Buy\" data-tweet=\"$SPOT - Spotify +5.9% amid Pivotal&#39;s boost back to Buy https://seekingalpha.com/news/3397014-spotifyplus-5_9-amid-pivotals-boost-back-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3397014-spotifyplus-5_9-amid-pivotals-boost-back-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397007\" data-ts=\"1539351911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397007-tsmc-win-all-orders-for-apples-a13-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSMC could win all orders for Apple&#39;s A13 chips</a></h4><ul><li>        Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) will win all the orders for Apple&rsquo;s A13 chips next year, according to <a href=\"https://www.digitimes.com/news/a20181011PD215.html\" target=\"_blank\">Digitimes sources</a>.</li><li>               TSMC&rsquo;s share of the global pure-play foundry market was 56% in 1H18. Keeping the A-series chip exclusivity could push the company to a 60%+ share in 2019.&nbsp;</li><li>               The company&rsquo;s 7nm process tech is also expected to land orders from AMD, Huawei, Nvidia, Qualcomm, and MediaTek. TSMC currently has fewer competitors in the space after Globalfoundries put its 7nm plans on hold.&nbsp;</li><li>               TSMC shares are&nbsp;<font color='green'>up 3%</font>&nbsp;to $40.11.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397007\" data-linked=\"TSMC could win all orders for Apple&#39;s A13 chips\" data-tweet=\"$TSM - TSMC could win all orders for Apple&#39;s A13 chips https://seekingalpha.com/news/3397007-tsmc-win-all-orders-for-apples-a13-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3397007-tsmc-win-all-orders-for-apples-a13-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397003\" data-ts=\"1539351357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397003-tobacco-sector-on-watch-after-noteworthy-fda-speech\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tobacco sector on watch after noteworthy FDA speech</a></h4><ul> <li>The tobacco sector is on watch after a striking speech by pharmacologist Lynn Hull of the FDA Center for Tobacco Products yesterday.</li> <li>While the speech was not official FDA policy, there's no ignoring that Hull highlighted the health benefits of a sharp reduction in nicotine in tobacco products for the U.S. population. \"Making all cigarettes minimally addictive could significantly reduce the morbidity and mortality caused by smoking,\" noted Hull.</li> <li>Hull seemed to indicate with her comments that the agency may be looking at implementing reduced nicotine standards as soon as 2020.</li> <li>Height Capital Markets maintains its outlook that 2024 is the earliest the FDA could finalize nicotine level regulations, although if the FDA issued a nicotine NPRM next year that timetable could be moved up.</li> <li>Keep an eye on Altria Group (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='red'>-1.5%</font>), Philip Morris International (<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a> <font color='red'>-1.2%</font>), British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color='red'>-1.3%</font>),  Imperial Brands (<a href='https://seekingalpha.com/symbol/IMBBF' title='Imperial Brands PLC'>OTCQX:IMBBF</a>), Japan Tobacco (<a href='https://seekingalpha.com/symbol/JAPAY' title='Japan Tobacco ADR'>OTCPK:JAPAY</a>) and gang today.</li> <li><a href=\"https://www.fda.gov/scienceresearch/aboutscienceresearchatfda/ucm486711.htm\" target=\"_blank\">FDA webcast</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397003\" data-linked=\"Tobacco sector on watch after noteworthy FDA speech\" data-tweet=\"$MO $MO $PM - Tobacco sector on watch after noteworthy FDA speech https://seekingalpha.com/news/3397003-tobacco-sector-on-watch-after-noteworthy-fda-speech?source=tweet\" data-url=\"https://seekingalpha.com/news/3397003-tobacco-sector-on-watch-after-noteworthy-fda-speech\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397000\" data-ts=\"1539350874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORI\" target=\"_blank\">CORI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397000-premarket-gainers-of-9-05-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (10/12/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CORI' title='Corium International, Inc.'>CORI</a> <font color='green'>+51%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3396836-corium-go-private-transaction-valued-500m\" target=\"_blank\">acquired</a> by Gurnet Point Capital.</li><li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+19%</font>.</li><li><a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396857-tetraphase-launches-eravacycline-u-s-shares-13-percent-hours\" target=\"_blank\">launching</a> eravacycline in U.S.</li><li><a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396963-iovance-prices-stock-offering-9_97-shares-8-percent-premarket\" target=\"_blank\">pricing</a> stock offering at $9.97.</li><li><a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+10%</font>&nbsp;on being <a href=\"https://seekingalpha.com/pr/17299057-cannabisnewswire-announces-cbd-key-myriad-health-products-across-globe\" target=\"_blank\">key</a> to myriad of health products across the globe as per CannabisNewsWire.</li><li><a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396993-new-age-beverages-hires-new-cfo\" target=\"_blank\">hiring</a> of new CFO.</li><li><a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='green'>+7%</font>&nbsp;as Wedbush <a href=\"https://seekingalpha.com/news/3396932-fitbit-plus-5_8-percent-wedbush-says-outperform\" target=\"_blank\">says Outperform</a>.</li><li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc'>SSRM</a> <font color='green'>+6%</font>&nbsp;on 3Q production results</a>.</li><li><a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/QD' title='Qudian, Inc.'>QD</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+6%</font>&nbsp;as Medical cannabis <a href=\"https://seekingalpha.com/news/3396969-medical-cannabis-okd-uk-effective-november-1\" target=\"_blank\">OK'd</a> in UK effective November 1.</li><li><a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396960-pivotal-upgrades-snap-says-go-private-snap-plus-4-percent\" target=\"_blank\">upgrade</a>.</li><li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+5%</font>\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3397000\" data-linked=\"Premarket Gainers as of 9:05 am (10/12/2018)\" data-tweet=\"$CORI $CORI $IGC - Premarket Gainers as of 9:05 am (10/12/2018) https://seekingalpha.com/news/3397000-premarket-gainers-of-9-05-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397000-premarket-gainers-of-9-05-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396998\" data-ts=\"1539350326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396998-noble-corpplus-8-after-finding-work-for-two-idle-drillships\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. +8% after finding work for two idle drillships</a></h4><ul><li>Noble Corp. (NYSE:<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a>)&nbsp;<font color='green'>+8.3%</font> pre-market after <a href=\"https://www.offshoreenergytoday.com/noble-finds-work-for-two-idle-drillships/\" target=\"_blank\">winning contracts for two of its idle drillships</a>, according to the company&rsquo;s <a href=\"https://seekingalpha.com/pr/17298606-noble-corporation-plc-provides-fleet-contract-status-update\" target=\"_blank\">latest fleet status report</a>.</li><li>NE says the <em>Noble Don Taylor</em> was awarded a contract by Talos Energy to start work in the&nbsp;U.S. Gulf of Mexico next month and ending in mid-January 2019; the dayrate is not disclosed but&nbsp;NE says the rig will collect a dayrate over the defined contract period in addition to the idle dayrate of $420K in accordance with Shell&rsquo;s decision from September to idle the rig&nbsp;for the remainder of its contract.</li><li>Also, the <em>Noble Globetrotter II</em> won a contract with Total for operations offshore Bulgaria starting next month and ending in early January; the dayrate is not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396998\" data-linked=\"Noble Corp. +8% after finding work for two idle drillships\" data-tweet=\"$NE - Noble Corp. +8% after finding work for two idle drillships https://seekingalpha.com/news/3396998-noble-corpplus-8-after-finding-work-for-two-idle-drillships?source=tweet\" data-url=\"https://seekingalpha.com/news/3396998-noble-corpplus-8-after-finding-work-for-two-idle-drillships\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396996\" data-ts=\"1539350142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396996-inseegoplus-2_1-on-roth-start-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego +2.1% on Roth start at Buy</a></h4><ul>   <li>Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color='green'>up 2.1%</font> premarket after an initiation at Buy by Roth Capital.</li>    <li>The firm's Scott Searle has a $5 price target, implying 48.4% upside.</li>    <li>Shares have pulled back a bit from <a href=\"https://seekingalpha.com/news/3390153-inseego-three-year-high-amid-verizon-service-rollout\" target=\"_blank\">three-year highs hit a month ago</a>, in the wake of new high-speed service rollouts from Verizon. They're still <font color='green'>up 72.8%</font> over the past quarter, making for 12-month <font color='green'>gains of 134%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3396996\" data-linked=\"Inseego +2.1% on Roth start at Buy\" data-tweet=\"$INSG - Inseego +2.1% on Roth start at Buy https://seekingalpha.com/news/3396996-inseegoplus-2_1-on-roth-start-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3396996-inseegoplus-2_1-on-roth-start-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396994\" data-ts=\"1539349760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMDZ\" target=\"_blank\">IMDZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396994-premarket-losers-of-9-05-10-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (10/12/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a>&nbsp;<font color='red'>-41%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396854-immune-design-bails-internal-development-cmb305-shares-slip-1-percent-hours\" target=\"_blank\">announcing</a> updates &amp; portfolio prioritization for G100 and CMB305.</li><li><a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3396900-verastem-oncology-prices-registered-direct-offering-150m-convertible-notes\" target=\"_blank\">pricing</a> registered direct offering of $150M convertible notes.</li><li><a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3396994\" data-linked=\"Premarket Losers as of 9:05 am (10/12/2018)\" data-tweet=\"$IMDZ $IMDZ $VSTM - Premarket Losers as of 9:05 am (10/12/2018) https://seekingalpha.com/news/3396994-premarket-losers-of-9-05-10-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3396994-premarket-losers-of-9-05-10-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396993\" data-ts=\"1539349572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396993-new-age-beverages-hires-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages hires new CFO</a></h4><ul> <li>Things are happening fast at New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>), including the <a href=\"https://newagebev.com/investors/\" target=\"_blank\">hiring</a> today of a new chief financial and administrative officer.</li> <li>Gregory Gould is joining the company after working as CFO at Evolce Biologics and Aytu Bioscience.</li> <li>Shares of New Age Beverages are <font color='green'>up 7.1%</font> in premarket trading to $6.36.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3396993\" data-linked=\"New Age Beverages hires new CFO\" data-tweet=\"$NBEV - New Age Beverages hires new CFO https://seekingalpha.com/news/3396993-new-age-beverages-hires-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3396993-new-age-beverages-hires-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396985\" data-ts=\"1539348715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396985-wells-fargo-jumps-2-in-premarket-after-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo jumps 2% in premarket after Q3 results</a></h4><ul><li>Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>)<font color='green'> rises 2.0%</font>&nbsp;in premarket trading even as<a href=\"https://seekingalpha.com/pr/17298955-wells-fargo-reports-6_0-billion-quarterly-net-income-diluted-eps-1_13\" target=\"_blank\"> Q3 EPS</a>, adjusted for redemption of preferred stock, fell short of consensus by three cents.</li><li>Q3 EPS was $1.13, excluding the effect of Series J preferred stock redemption, EPS would have been $1.16. That compares with 98 cents in Q2 and 83 cents a year ago.</li><li>\"We saw positive business trends in the third quarter, including growth in primary consumer checking customers, increased debit and credit card usage, and higher year-over-year loan originations in auto, small business, home equity and personal loans and lines,\" says CFO John Shrewsberry.</li><li>Q3 net interest income $12.6B, up $31M from Q2 and up 1% from a year ago; net interest margin 2.94% improved 1 basis point from Q2 and up 8 bps from a year earlier.</li><li>Total average loans of $939.5B, fell $4.6B from Q2; commercial loans fell $1.2B from June 30, 2018, predominantly from a $2.8B decline in commercial real estate loans, partly offset by $1.5B growth in commercial and industrial loans.</li><li>Total average deposits $1.3T, down $5.0B from Q2.</li><li>Net loan charge-off rate 0.29% vs. 0.26% in Q2 and 0.30% a year ago.</li><li>Net income by segment:</li></ul><ol><li>Community Banking $2.82B vs. $2.50B in Q2 and $1.88B a year ago.</li><li>Wholesale Banking $2.85B vs. $2.64B in Q2 and $2.31B a year ago.</li><li>Wealth and Investment Management $732M vs. $445M in Q2 and $719M a year ago.</li></ol><ul><li>ROE 12.0% vs. 10.6% at Q2 end and 9.0% at Q3 2017 end.</li><li>Book value per common share $37.55 vs. $37.41 in prior quarter and $36.92 a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396954-wells-fargo-misses-0_03-beats-revenue\" target=\"_blank\">Wells Fargo misses by $0.03, beats on revenue</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396985\" data-linked=\"Wells Fargo jumps 2% in premarket after Q3 results\" data-tweet=\"$WFC - Wells Fargo jumps 2% in premarket after Q3 results https://seekingalpha.com/news/3396985-wells-fargo-jumps-2-in-premarket-after-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3396985-wells-fargo-jumps-2-in-premarket-after-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396984\" data-ts=\"1539348594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396984-pure-storageplus-3_6-on-affiliates-ipo-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Storage +3.6% on affiliate&#39;s IPO pricing</a></h4><ul><li>        Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>)&nbsp;<font color='green'>gains 3.6%</font>&nbsp;premarket after its European affiliate Shurgard prices its Europe IPO at &euro;23, the bottom end of &euro;23 to &euro;28 range.</li><li>               Shurgard, the region&rsquo;s largest self-storage provider, will raise &euro;575M in the offering with a &euro;2.04B valuation.&nbsp;</li><li>                  Public Storage owns 49% of Shurgard.    </li><li>               Sources:<a href=\"https://www.cnbc.com/2018/10/12/stocks-making-the-biggest-move-premarket-jpm-pnc-msft-el-intc--more.html\" target=\"_blank\"> CNBC</a>/<a href=\"https://www.reuters.com/article/shurgard-sse-ipo/shurgard-self-storage-prices-ipo-at-bottom-of-indicative-range-idUSL8N1WS12E\" target=\"_blank\">Reuters</a>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3396984\" data-linked=\"Pure Storage +3.6% on affiliate&#39;s IPO pricing\" data-tweet=\"$PSTG - Pure Storage +3.6% on affiliate&#39;s IPO pricing https://seekingalpha.com/news/3396984-pure-storageplus-3_6-on-affiliates-ipo-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3396984-pure-storageplus-3_6-on-affiliates-ipo-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396976\" data-ts=\"1539347785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396976-intels-asml-stake-drops-below-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel&#39;s ASML stake drops below 3%</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) reduces its stake in supplier ASML (NASDAQ:<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a>) to 2.99%, according to an <a href=\"https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=63787\" target=\"_blank\">AFM update</a>.</li><li>               Intel originally bought a stake in 2012 to help fund ASML&rsquo;s next-gen lithography systems.&nbsp;</li><li>               Last December, the Netherlands&rsquo; Authority for Financial Markets said Intel&rsquo;s stake had fallen below the 5% reporting threshold.&nbsp;</li><li>               Intel shares are&nbsp;<font color='green'>up 2.2%</font>&nbsp;premarket to $45.20.&nbsp;</li><li>               ASML shares are&nbsp;<font color='green'>up 1.7%</font>&nbsp;to $174.69.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3396976\" data-linked=\"Intel&#39;s ASML stake drops below 3%\" data-tweet=\"$INTC $INTC $ASML - Intel&#39;s ASML stake drops below 3% https://seekingalpha.com/news/3396976-intels-asml-stake-drops-below-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3396976-intels-asml-stake-drops-below-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396970\" data-ts=\"1539347278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLF\" target=\"_blank\">XLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396970-markets-set-for-sizable-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Markets set for sizable bounce</a></h4><ul><li>Following two days of big losses, S&amp;P 500 futures are&nbsp;<font color='green'>higher by 1%</font>&nbsp;with just over an hour to go before the opening bell. DJIA futures are also&nbsp;<font color='green'>up 1%</font>, and Nasdaq futures&nbsp;<font color='green'>up 1.5%</font>.</li><li>The Financial Select Sector SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>) is&nbsp;<font color='green'>ahead 2%</font>, led by earnings-related gains from JPMorgan, Citigroup, and Wells Fargo.</li><li>The 10-year Treasury yield is up nearly two basis points to 3.17%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396967-citigroup-climbs-2-percent-q3-beat\" target=\"_blank\">Citigroup climbs 2% after Q3 beat</a> (Oct. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396939-jpmorgan-gains-1_4-percent-q3-beat-strong-consumer-banking-growth\" target=\"_blank\">JPMorgan gains 1.4% after Q3 beat on strong consumer banking growth</a> (Oct. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396954-wells-fargo-misses-0_03-beats-revenue\" target=\"_blank\">Wells Fargo misses by $0.03, beats on revenue</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396970\" data-linked=\"Markets set for sizable bounce\" data-tweet=\"$XLF - Markets set for sizable bounce https://seekingalpha.com/news/3396970-markets-set-for-sizable-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/3396970-markets-set-for-sizable-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396968\" data-ts=\"1539347017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396968-twitterplus-2_6-on-pivotal-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +2.6% on Pivotal upgrade</a></h4><ul><li>        Pivotal Research <a href=\"https://www.cnbc.com/2018/10/12/stocks-making-the-biggest-move-premarket-jpm-pnc-msft-el-intc--more.html\" target=\"_blank\">upgrades</a> Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) from Sell to Hold with a $24 target.</li><li>               The firm cites this week&rsquo;s pullback in share prices.&nbsp;</li><li>               Twitter shares are&nbsp;<font color='green'>up 2.6%</font>&nbsp;premarket to $27.70.&nbsp; Shares are&nbsp;<font color='red'>down 4.4%</font>&nbsp;this week,<font color='red'> 9.2%</font>&nbsp;in the past month,&nbsp;<font color='red'>39.3%</font>&nbsp;in the quarter, but up 12.5% YTD.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396960-pivotal-upgrades-snap-says-go-private-snap-plus-4-percent\" target=\"_blank\">Pivotal upgrades Snap, says it could go private; SNAP +4%</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396968\" data-linked=\"Twitter +2.6% on Pivotal upgrade\" data-tweet=\"$TWTR - Twitter +2.6% on Pivotal upgrade https://seekingalpha.com/news/3396968-twitterplus-2_6-on-pivotal-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3396968-twitterplus-2_6-on-pivotal-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396967\" data-ts=\"1539347006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396967-citigroup-climbs-2-after-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup climbs 2% after Q3 beat</a></h4><ul><li>Citigroup (NYSE:<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>)<font color='green'> climbs 2%&nbsp;</font>in premarket trading after&nbsp;<a href=\"https://seekingalpha.com/pr/17298954-citigroup-reports-third-quarter-2018-financial-results\" target=\"_blank\">Q3 EPS of $1.73</a> beat consensus of $1.68 and compares with $1.42 a year ago; net income rose to $4.62B from $4.49B in Q2 and $4.13B a year ago.</li><li>&ldquo;Our results this quarter showed solid year-over-year revenue growth across many of our businesses, including Fixed Income, Treasury&nbsp;and Trade Solutions, Securities Services, the Private Bank, and our consumer franchise in&nbsp;Mexico,\" says Citi CEO Michael Corbat.</li><li>Effective tax rate 24% vs 34% a year ago.</li><li>Net income by segment:</li></ul><ol><li>Global Consumer Banking $1.57B, up 23% Q/Q, up 34% Y/Y.</li><li>Institutional Clients Group $3.12B, down 3% Q/Q, up 2% Y/Y; fixed income revenue $3.20B, up 4% Q/Q and 9% Y/Y.</li><li>Corporate/Other loss $67M, compares with $13M loss in Q2 and $83M loss in Q3 2017.</li></ol><ul><li>Q3 return on average common equity 9.6% vs. 9.2% in Q2 and 7.3% in Q3 2017; common equity Tier 1 capital ratio 11.8% vs. !2.1% in Q2 and 13.0% a year ago.</li><li>Book value per share rose to $72.88&nbsp; vs $71.95 in Q2 and $78.81 a year ago.</li><li>End-of-period loans $675B, up 3% Y/Y, ex-forex up 4%; end-of period deposits $1.0T, up 4% Y/Y, ex-forex up 5%.</li><li>Q3 total cost of credit $1.97B, up 9% Q/Q, down 1% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396950-citigroup-beats-0_05-misses-revenue\" target=\"_blank\">Citigroup beats by $0.05, misses on revenue</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396967\" data-linked=\"Citigroup climbs 2% after Q3 beat\" data-tweet=\"$C - Citigroup climbs 2% after Q3 beat https://seekingalpha.com/news/3396967-citigroup-climbs-2-after-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3396967-citigroup-climbs-2-after-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396966\" data-ts=\"1539346784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396966-activision-up-nearly-4-after-latest-call-of-duty-release\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision up nearly 4% after latest Call of Duty release</a></h4><ul><li>COD: Black Ops IV was released overnight to mostly positive reviews (according to Baird).</li><li><a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>&nbsp;<font color='green'>+3.9%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3396966\" data-linked=\"Activision up nearly 4% after latest Call of Duty release\" data-tweet=\"$ATVI - Activision up nearly 4% after latest Call of Duty release https://seekingalpha.com/news/3396966-activision-up-nearly-4-after-latest-call-of-duty-release?source=tweet\" data-url=\"https://seekingalpha.com/news/3396966-activision-up-nearly-4-after-latest-call-of-duty-release\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396963\" data-ts=\"1539346567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOVA\" target=\"_blank\">IOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396963-iovance-prices-stock-offering-9_97-shares-up-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iovance prices stock offering at $9.97; shares up 8% premarket</a></h4><ul><li>Iovance Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a>) <a href=\"https://seekingalpha.com/pr/17298945-iovance-biotherapeutics-inc-announces-pricing-public-offering-approximately-220-million\" target=\"_blank\">prices </a>its public offering of 22M shares of common stock at $9.97, yesterday's close. Underwriters over-allotment is an additional 3.3M shares. Closing date is October 16.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396963\" data-linked=\"Iovance prices stock offering at $9.97; shares up 8% premarket\" data-tweet=\"$IOVA - Iovance prices stock offering at $9.97; shares up 8% premarket https://seekingalpha.com/news/3396963-iovance-prices-stock-offering-9_97-shares-up-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3396963-iovance-prices-stock-offering-9_97-shares-up-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396961\" data-ts=\"1539346376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396961-arcelormittal-to-sell-assets-to-liberty-house-part-of-ilva-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal to sell assets to Liberty House, part of Ilva deal</a></h4><ul>     <li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>)&nbsp;<font color='green'>+2%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17298845-arcelormittal-reaches-agreement-liberty-house-sale-steelmaking-facilities-czech-republic\" target=\"_blank\">agreeing to sell</a> its steelmaking facilities in the Czech Republic, Romania, Macedonia and Italy to Liberty House Group; financial terms are not disclosed.</li>     <li>The sales <a href=\"https://www.reuters.com/article/us-ilva-m-a-arcelormittal/arcelormittal-to-sell-assets-to-liberty-house-as-part-of-ilva-deal-idUSKCN1MM0U2\" target=\"_blank\">satisfy part of an agreement</a> with the European Commission related to MT&rsquo;s acquisition of Italian steelmaker Ilva.</li>     <li>MT says negotiations are ongoing with parties for the sale of the other assets in Luxembourg and Belgium which were included in the divestment agreement with the EC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396961\" data-linked=\"ArcelorMittal to sell assets to Liberty House, part of Ilva deal\" data-tweet=\"$MT - ArcelorMittal to sell assets to Liberty House, part of Ilva deal https://seekingalpha.com/news/3396961-arcelormittal-to-sell-assets-to-liberty-house-part-of-ilva-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3396961-arcelormittal-to-sell-assets-to-liberty-house-part-of-ilva-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396960\" data-ts=\"1539346235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396960-pivotal-upgrades-snap-says-go-private-snapplus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal upgrades Snap, says it could go private; SNAP +4%</a></h4><ul><li>        Pivotal upgrades Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) to Buy with an $8 price target, a 17.5% upside to yesterday&rsquo;s close.</li><li>               Pivotal senior research analyst Brian Wieser, in an <a href=\"https://www.cnbc.com/2018/10/12/snap-could-go-private-if-it-cant-get-people-to-stay-on-snapchat.html\" target=\"_blank\">email to CNBC</a>: &ldquo;The data we look at is showing a widening user base, although one which is collectively reducing its time on the platform. Our take is that it is not too late for management to find ways to reverse recent usage trends and generally improve monetization regardless of those usage trends.&rdquo;&nbsp;</li><li>               Wieser says if management were to fail at this, Snap &ldquo;could become an attractive candidate to go private.&rdquo;&nbsp;</li><li>               Snap shares are&nbsp;<font color='green'>up 4.4%</font>&nbsp;premarket to $7.11.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3396960\" data-linked=\"Pivotal upgrades Snap, says it could go private; SNAP +4%\" data-tweet=\"$SNAP - Pivotal upgrades Snap, says it could go private; SNAP +4% https://seekingalpha.com/news/3396960-pivotal-upgrades-snap-says-go-private-snapplus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3396960-pivotal-upgrades-snap-says-go-private-snapplus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396959\" data-ts=\"1539346146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396959-trevena-down-13-premarket-after-negative-ad-com-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trevena down 13% premarket after negative Ad Com vote</a></h4><ul><li>Trevena (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>) is down&nbsp;<font color='red'>13%</font>&nbsp;premarket on modest volume following yesterday's close, but negative, Ad Com vote on pain med oliceridine.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396817-ad-com-thumbs-trevenas-oliceridine\" target=\"_blank\">Ad Com thumbs down on Trevena's oliceridine</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396959\" data-linked=\"Trevena down 13% premarket after negative Ad Com vote\" data-tweet=\"$TRVN - Trevena down 13% premarket after negative Ad Com vote https://seekingalpha.com/news/3396959-trevena-down-13-premarket-after-negative-ad-com-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/3396959-trevena-down-13-premarket-after-negative-ad-com-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396957\" data-ts=\"1539345948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396957-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) initiated with Buy rating and $17 (70% upside) price target at Mizuho Securities.</li><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) initiated with Outperform rating and $170 (39% upside) price target at Bernstein.</li><li>Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco'>ELAN</a>) initiated with Hold rating at Craig Hallum.</li><li>Alder Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a>) downgraded to Neutral with a $15 (12% upside) price target at Mizuho.</li><li>Aphria (APHQF) downgraded to Sell with a C$19 (4% downside risk) price target at Veritas.</li><li>Allscripts (NASDAQ:<a href='https://seekingalpha.com/symbol/MDRX' title='Allscripts Healthcare Solutions, Inc.'>MDRX</a>) downgraded to Neutral at Evercore ISI.</li><li>Molina Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) downgraded to Hold with a $152 (10% upside) price target at Jefferies. Shares down a fraction premarket.</li><li>Immune Design (NASDAQ:<a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a>) downgraded to Market Perform at Leerink Partners following company's announced termination of internal development of CMB305.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396957\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ABEO $ABEO $SRPT - Premarket analyst action - healthcare https://seekingalpha.com/news/3396957-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3396957-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396954\" data-ts=\"1539345749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396954-wells-fargo-misses-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo misses by $0.03, beats on revenue</a></h4><ul><li>Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>): Q3 Non-GAAP EPS of $1.16 <span style=\"color:red\">misses by $0.03</span>; GAAP EPS of $1.13 <span style=\"color:red\">misses by $0.06</span>.</li><li>Revenue of $21.94B (+0.4% Y/Y) <font color='green'>beats by $100M</font>.</li><li>Shares <font color='green'>+1.5%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17298955-wells-fargo-reports-6_0-billion-quarterly-net-income-diluted-eps-1_13'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3396954\" data-linked=\"Wells Fargo misses by $0.03, beats on revenue\" data-tweet=\"$WFC - Wells Fargo misses by $0.03, beats on revenue https://seekingalpha.com/news/3396954-wells-fargo-misses-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3396954-wells-fargo-misses-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396950\" data-ts=\"1539345653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396950-citigroup-beats-0_05-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup beats by $0.05, misses on revenue</a></h4><ul><li>Citigroup (NYSE:<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>): Q3 GAAP EPS of $1.73 <span style=\"color:green\">beats by $0.05</span>.</li><li>Revenue of $18.39B (-0.2% Y/Y) <font color='red'>misses by $60M</font>.</li><li>Shares <font color='green'>+2%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17298954-citigroup-reports-third-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3396950\" data-linked=\"Citigroup beats by $0.05, misses on revenue\" data-tweet=\"$C - Citigroup beats by $0.05, misses on revenue https://seekingalpha.com/news/3396950-citigroup-beats-0_05-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3396950-citigroup-beats-0_05-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396944\" data-ts=\"1539344940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396944-auris-medical-to-provide-update-on-intranasal-betahistine-program-on-october-17-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris Medical to provide update on intranasal betahistine program on October 17; shares up 10% premarket</a></h4><ul> <li>Auris Medical Holding AG (NASDAQ:<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a>) will <a href=\"https://seekingalpha.com/pr/17298940-auris-medical-provide-update-intranasal-betahistine-program-wednesday-october-17-2018\" target=\"_blank\">hold</a> a conference call on Wednesday, October 17 at&nbsp;8:00 am ET (2:00 pm CET) to provide update on its intranasal betahistine program, including key results from the second Phase 1 trial.</li><li>Shares are up&nbsp;<font color='green'>10%</font>&nbsp;premarket.</li>             </ul><div class=\"tiny-share-widget\" data-id=\"3396944\" data-linked=\"Auris Medical to provide update on intranasal betahistine program on October 17; shares up 10% premarket\" data-tweet=\"$EARS - Auris Medical to provide update on intranasal betahistine program on October 17; shares up 10% premarket https://seekingalpha.com/news/3396944-auris-medical-to-provide-update-on-intranasal-betahistine-program-on-october-17-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3396944-auris-medical-to-provide-update-on-intranasal-betahistine-program-on-october-17-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396941\" data-ts=\"1539344483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396941-citi-upgrades-netflix-after-tech-rout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi upgrades Netflix after tech rout</a></h4><ul> <li>Citi issues a recommendation that investors buy Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) amid the tech slump in the U.S.</li> <li>The investment firm makes what it calls an \"opportunistic upgrade\" on Netflix to Buy from Neutral.</li><li>Citi analyst Mark May and team set a price target of $375.</li> <li>Netflix is due to report earnings next week.</li> <li>Shares of Netflix are <font color='green'>up 3.71%</font> in premarket trading to $333.01.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3396941\" data-linked=\"Citi upgrades Netflix after tech rout\" data-tweet=\"$NFLX - Citi upgrades Netflix after tech rout https://seekingalpha.com/news/3396941-citi-upgrades-netflix-after-tech-rout?source=tweet\" data-url=\"https://seekingalpha.com/news/3396941-citi-upgrades-netflix-after-tech-rout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396940\" data-ts=\"1539344482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396940-tyme-techs-lead-drug-smminus-88-to-be-investigated-in-phase-2-3-study-in-pancreatic-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Tech&#39;s lead drug SM-88 to be investigated in Phase 2/3 study in pancreatic cancer</a></h4><ul><li>Thinly traded micro cap Thyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) has seen a&nbsp;<font color='green'>14%</font>&nbsp;bump in price over the past two days in response to its <a href=\"https://seekingalpha.com/pr/17295788-tyme-s-smminus-88-included-pancreatic-cancer-action-network-s-pancan-s-novel-precision\" target=\"_blank\">announcement </a>that the non-profit Pancreatic Cancer Action Network (<a href=\"https://www.pancan.org/about-us/our-leadership/\" target=\"_blank\">PanCAN</a>) was agreed to include lead candidate <a href=\"https://www.tymeinc.com/sm-88/what-is-sm-88/default.aspx\" target=\"_blank\">SM-88</a> in a Phase 2/3 clinical trial.</li><li>The initial objective will be to evaluate SM-88, a combo therapy of a tyrosine derivative and rapamycin, phenytoin and methoxsalen, as monotherapy in patients who have failed to respond to one prior line of chemo.</li><li>The plan also includes assessing the combination of SM-88 and gemcitabine and Celgene's Abraxane (nab-paclitaxel) in first-line and second-line settings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396940\" data-linked=\"Tyme Tech&#39;s lead drug SM-88 to be investigated in Phase 2/3 study in pancreatic cancer\" data-tweet=\"$TYME - Tyme Tech&#39;s lead drug SM-88 to be investigated in Phase 2/3 study in pancreatic cancer https://seekingalpha.com/news/3396940-tyme-techs-lead-drug-smminus-88-to-be-investigated-in-phase-2-3-study-in-pancreatic-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3396940-tyme-techs-lead-drug-smminus-88-to-be-investigated-in-phase-2-3-study-in-pancreatic-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396935\" data-ts=\"1539343982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396935-microsoftplus-3-after-macquarie-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft +3% after Macquarie upgrade</a></h4><ul><li>        Macquarie <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Macquarie+Upgrades+Microsoft+%28MSFT%29+to+Outperform/14699721.html\" target=\"_blank\">upgrades</a> Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) from Neutral to Outperform with a $121 price target, a 14% upside to yesterday&rsquo;s close.</li><li>               Analyst Sarah Hindlian cites recent spending checks and long-term trends, calling the company &ldquo;a name we have sorely missed.&rdquo;&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='green'>up 3.1%</font>&nbsp;premarket to $109.20.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3396935\" data-linked=\"Microsoft +3% after Macquarie upgrade\" data-tweet=\"$MSFT - Microsoft +3% after Macquarie upgrade https://seekingalpha.com/news/3396935-microsoftplus-3-after-macquarie-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3396935-microsoftplus-3-after-macquarie-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396934\" data-ts=\"1539343608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396934-bristol-myers-squibbs-opdivo-flunks-late-stage-lung-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers Squibb&#39;s Opdivo flunks late-stage lung cancer study</a></h4><ul><li>An open-label Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02481830?term=checkmate-331&amp;rank=1\" target=\"_blank\">CheckMate-331</a>, evaluating Bristol-Myers Squibb's (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) Opdivo (nivolumab) versus standard-of-care chemo (topotecan or amrubicin) in patients with relapsed small cell lung cancer &#40;SCLC&#41; <a href=\"https://seekingalpha.com/pr/17298896-bristol-myers-squibb-announces-phase-3-checkmate-minus-331-study-meet-primary-endpoint\" target=\"_blank\">failed to achieve the primary endpoint</a> of overall survival &#40;OS&#41;.</li><li>Other studies in SCLC are either ongoing or about to start, including a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03670056?cond=Small-cell+Lung+Cancer&amp;intr=nivolumab&amp;rank=2\" target=\"_blank\">Phase 2</a> evaluating Opdivo + Yervoy (ipilimumab) in patients who have previously received platinum-based chemo.</li></ul><div class=\"tiny-share-widget\" data-id=\"3396934\" data-linked=\"Bristol-Myers Squibb&#39;s Opdivo flunks late-stage lung cancer study\" data-tweet=\"$BMY - Bristol-Myers Squibb&#39;s Opdivo flunks late-stage lung cancer study https://seekingalpha.com/news/3396934-bristol-myers-squibbs-opdivo-flunks-late-stage-lung-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3396934-bristol-myers-squibbs-opdivo-flunks-late-stage-lung-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396932\" data-ts=\"1539343406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396932-fitbitplus-5_8-wedbush-says-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit +5.8% as Wedbush says Outperform</a></h4><ul><li>        Wedbush Securities upgrades Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) from Neutral to Outperform with a $6.50 price target, a 44% upside to yesterday&rsquo;s close. (Source: StreetAccount.)</li><li>               Fitbit&rsquo;s Charge 3 hit stores on October 7 with a high-res touchscreen, improved heart and oxygen sensors, and up to seven days of battery life.&nbsp;</li><li>               FIT shares are&nbsp;<font color='green'>up 5.8%</font>&nbsp;premarket to $4.76. Shares are&nbsp;<font color='red'>down 10%&nbsp;</font>this week,&nbsp;<font color='red'>18.6%</font>&nbsp;in the month,&nbsp;<font color='red'>12.3%</font>&nbsp;in the quarter, and&nbsp;<font color='red'>21%</font>&nbsp;YTD.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395169-fitbits-charge-3-will-release-october-7\" target=\"_blank\">Fitbit's Charge 3 will release October 7</a> (Oct. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396932\" data-linked=\"Fitbit +5.8% as Wedbush says Outperform\" data-tweet=\"$FIT - Fitbit +5.8% as Wedbush says Outperform https://seekingalpha.com/news/3396932-fitbitplus-5_8-wedbush-says-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3396932-fitbitplus-5_8-wedbush-says-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396931\" data-ts=\"1539342963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396931-pnc-sinks-premarket-even-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PNC sinks premarket even with Q3 beat</a></h4><ul><li>PNC Financial Services (NYSE:<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a>)<font color='red'> falls 2.4%</font>&nbsp;in premarket trading even as Q3 EPS of<a href=\"https://seekingalpha.com/pr/17298891-pnc-reports-third-quarter-2018-net-income-1_4-billion-2_82-diluted-eps\" target=\"_blank\"> $2.82</a> beat consensus of $2.73. EPS rose from $2.72 in Q2 and $2.16 in the year ago quarter.</li><li>Net interest income of $2.47B, rose 2% from Q2 and 5% Y/Y; higher loan yields and securities balances and an additional day in Q3 (vs. Q2) was partly offset by increased funding costs.</li><li>Net interest margin of 2.99%, up 3 basis points from Q2, and up 8 bps from Q3 2017.</li><li>Average loans of $223.3B, up $0.7B from Q2 and up 2% Y/Y.</li></ul><ol><li>Average commercial lending balances grew $0.2B, with loan growth moderated by substantial payoff volumes;</li><li>Average consumer lending balances increased $0.5B Q/Q; growth in auto, residential mortgage, credit-card, and unsecured installment loans partly offset by lower home equity and education loans.</li></ol><ul><li>Provision for credit losses of $88M vs. $80M in Q2 and $130M in the year-ago quarter; net charge-offs fell to $91M from $109M in Q2 and $106M a year earlier.</li><li>Return on average common equity 12.32% vs. 12.13% in Q2 and 9.89% in Q3 2017.</li><li>Book value per common share $93.22 at Q3 end vs. $92.26 at Q2 end.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396923-pnc-financial-beats-0_09-beats-revenue\" target=\"_blank\">PNC Financial beats by $0.09, beats on revenue</a> (Oct. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396910-futures-rise-earnings-season-begins\" target=\"_blank\">Futures rise as earnings season begins</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3396931\" data-linked=\"PNC sinks premarket even with Q3 beat\" data-tweet=\"$PNC - PNC sinks premarket even with Q3 beat https://seekingalpha.com/news/3396931-pnc-sinks-premarket-even-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3396931-pnc-sinks-premarket-even-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396929\" data-ts=\"1539342520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396929-acelrx-shares-halted-pending-todays-ad-com-vote-on-dsuvia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AcelRx shares halted pending today&#39;s Ad Com vote on Dsuvia</a></h4><ul><li>Nasdaq has suspended trading in AcelRx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) pending the outcome of today's Ad Com review of its marketing application seeking approval for pain med DSUVIA (sufentanil sublingual tablet).</li></ul><div class=\"tiny-share-widget\" data-id=\"3396929\" data-linked=\"AcelRx shares halted pending today&#39;s Ad Com vote on Dsuvia\" data-tweet=\"$ACRX - AcelRx shares halted pending today&#39;s Ad Com vote on Dsuvia https://seekingalpha.com/news/3396929-acelrx-shares-halted-pending-todays-ad-com-vote-on-dsuvia?source=tweet\" data-url=\"https://seekingalpha.com/news/3396929-acelrx-shares-halted-pending-todays-ad-com-vote-on-dsuvia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396925\" data-ts=\"1539341591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396925-jpm-kicks-off-earnings-season-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPM kicks off earnings season with a beat</a></h4><ul><li>JPMorgan Chase (NYSE:<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a>): Q3 GAAP EPS of $2.34&nbsp;<font color='green'>beats by $0.08</font>.</li><li>Revenue of $27.82B (+5.2% Y/Y) <font color='green'>beats by $380M</font>.</li><li>Shares <font color='green'>+1.7%</font> PM.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/19617/000001961718000196/a3q18erfexhibit991narrative.htm\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3396925\" data-linked=\"JPM kicks off earnings season with a beat\" data-tweet=\"$JPM - JPM kicks off earnings season with a beat https://seekingalpha.com/news/3396925-jpm-kicks-off-earnings-season-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3396925-jpm-kicks-off-earnings-season-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396923\" data-ts=\"1539341327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396923-pnc-financial-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PNC Financial beats by $0.09, beats on revenue</a></h4><ul><li>PNC Financial (NYSE:<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a>): Q3 GAAP EPS of $2.82 <span style=\"color:green\">beats by $0.09</span>.</li><li>Revenue of $4.36B (+5.6% Y/Y) <font color='green'>beats by $10M</font>.</li><li>Shares <font color='green'>+1.06%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17298891-pnc-reports-third-quarter-2018-net-income-1_4-billion-2_82-diluted-eps'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3396923\" data-linked=\"PNC Financial beats by $0.09, beats on revenue\" data-tweet=\"$PNC - PNC Financial beats by $0.09, beats on revenue https://seekingalpha.com/news/3396923-pnc-financial-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3396923-pnc-financial-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3396915\" data-ts=\"1539339513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHB\" target=\"_blank\">APHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3396915-ampliphi-biosciences-prices-6_6m-equity-offering-shares-down-34-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmpliPhi Biosciences prices $6.6M equity offering; shares down 34% premarket</a></h4><ul> <li>AmpliPhi Biosciences (NYSEMKT:<a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a>) <a href=\"https://seekingalpha.com/pr/17298864-ampliphi-biosciences-announces-pricing-6_6-million-underwritten-public-offering\" target=\"_blank\">prices</a> its public offering of 16,537,500 shares of common       stock and warrants to purchase up to 16,537,500 common shares and pre-funded warrants at a combined price of $0.40.</li>          <li>Underwriters over-allotment is an additional 2,480,625 shares of common stock and/or common       warrants.</li>     <li>The net proceeds of ~$6.2M will ve used for general corporate purposes, including       manufacturing, R&amp;D and G&amp;A expenses.</li><li>Closing date is October 16.</li><li>Shares are down&nbsp;<font color='red'>34%</font>&nbsp;premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3396915\" data-linked=\"AmpliPhi Biosciences prices $6.6M equity offering; shares down 34% premarket\" data-tweet=\"$APHB $ARMP - AmpliPhi Biosciences prices $6.6M equity offering; shares down 34% premarket https://seekingalpha.com/news/3396915-ampliphi-biosciences-prices-6_6m-equity-offering-shares-down-34-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3396915-ampliphi-biosciences-prices-6_6m-equity-offering-shares-down-34-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}